Total Return chart Hanmi Pharm. Co., Ltd.

Equities

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-21 pm EDT			5-day change	1st Jan Change
309,500 ^KRW	-1.28%		-2.21%	-12.20%

May. 08	Invion Partners with Hanlim Pharma for Glioblastoma Treatment	MT
May. 01	Hanmi Pharm Q1 Profit Surges 27.5%, Sales Up 11.8%	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.